Exendin-4 Emerging Therapeutic Potential in Dermatology
Journal of Pioneering Medical Sciences · 2026-03-05 · 15 (02) · 93-95
DOI: 10.47310/jpms2026150212 ↗At a glance
Journal article in Journal of Pioneering Medical Sciences, published online on 2026-03-05. Written by Ahmed El-Sayed Hassan and 6 co-authors.
Abstract (original language)
Exendin-4 is a synthetic analogue of the glucagon-like peptide-1 (GLP-1) that has a potent GLP-1 receptor agonist activity primarily approved for the treatment of Type 2 Diabetes Mellitus. Beyond its well-established metabolic actions, research has increasingly revealed the pleiotropic effects of Exendin-4, particularly in regulating inflammation, cellular proliferation, and tissue repair. Given that many dermatological conditions, including psoriasis and chronic wounds, share underlying pathogenic mechanisms such as systemic inflammation and impaired healing, the role of Exendin-4 in skin disorders presents a promising avenue for therapeutic exploration. This review examines the current evidence, primarily from in vitro and animal studies, regarding the direct and indirect influence of Exendin-4 on skin pathology, focusing on its impact on inflammatory dermatoses, wound healing and potential anti-cancer effects.
Cite
APA
Hassan, A. E., Fahmy, E. K., Ismail, M. M., Mosaed, M. M., BV, P., Alsel, B. A., & Salama, B. (2026). Exendin-4 Emerging Therapeutic Potential in Dermatology. Journal of Pioneering Medical Sciences, 15(02), 93-95. https://doi.org/10.47310/jpms2026150212
Vancouver
Hassan AE, Fahmy EK, Ismail MM, Mosaed MM, BV P, Alsel BA, et al. Exendin-4 Emerging Therapeutic Potential in Dermatology. Journal of Pioneering Medical Sciences. 2026;15(02):93-95. doi:10.47310/jpms2026150212
BibTeX
@article{Hassan2026,
author = {Hassan, Ahmed El-Sayed and Fahmy, Eslam Kamal and Ismail, Mohammed M. and Mosaed, Mohammed M. and BV, Padmanabha and Alsel, Baraah Abu and Salama, Basem},
title = {Exendin-4 Emerging Therapeutic Potential in Dermatology},
journal = {Journal of Pioneering Medical Sciences},
year = {2026},
volume = {15},
number = {02},
pages = {93--95},
doi = {10.47310/jpms2026150212}
}
EUVIMED